Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function


[Journal of the American Medical Association, January 01, 0001] November 14, 2011 -- A study that involved patients at the Minneapolis Heart Institute Foundation found that giving patients stem cell therapy two or three weeks after angioplasty did not improve heart function.

Cardiologist Jay Traverse, MD, of the Minneapolis Heart Institute at Abbott Northwestern Hospital and lead study author, presented the study's six-months result at the American Heart Association conference the same day it was published in JAMA. A summary can be seen here.

Share this article